Literature DB >> 20541716

Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease:the Dallas Heart Study.

Sachin Gupta1, Jarett D Berry, Colby R Ayers, Ronald M Peshock, Amit Khera, James A de Lemos, Parag C Patel, David W Markham, Mark H Drazner.   

Abstract

OBJECTIVES: To examine whether individuals with low short-term risk of coronary heart disease but high lifetime predicted risk of cardiovascular disease (CVD) have greater prevalence of left ventricular (LV) hypertrophy and increased aortic wall thickness (AWT) than those with low short-term and low lifetime risk.
BACKGROUND: Lifetime risk prediction can be used for stratifying individuals younger than 50 years of age into 2 groups: low short-term/high lifetime and low short-term/low lifetime predicted risk of CVD. Individuals with low short-term/high lifetime risk have a greater burden of subclinical atherosclerosis as measured by coronary artery calcium and carotid intima-media thickness. However, >75% of individuals with low short-term/high lifetime risk do not have detectable coronary artery calcium, suggesting the presence of alternative subclinical abnormalities.
METHODS: We stratified 1,804 Dallas Heart Study subjects between the ages of 30 and 50 years who had cardiac magnetic resonance into 3 groups: low short-term (<10% 10-year risk of coronary heart disease)/low lifetime predicted risk (<39% lifetime risk of CVD), low short-term (<10%)/high lifetime risk (> or =39%), and high short-term risk (> or =10%, prevalent diabetes, or previous stroke, or myocardial infarction). In those with low short-term risk, we compared measures of LV hypertrophy and AWT between those with low versus high lifetime risk.
RESULTS: Subjects with low short-term/high lifetime risk compared with those with low short-term/low lifetime risk had increased LV mass (men: 95 +/- 17 g/m(2) vs. 90 +/- 12 g/m(2) and women: 75 +/- 14 g/m(2) vs. 71 +/- 10 g/m(2), respectively; p < 0.001 for both). LV concentricity (mass/volume), wall thickness, and AWT were also significantly greater in those with high lifetime risk in this comparison (p < 0.001 for all), but LV end-diastolic volume was not (p > 0.3). These associations persisted among participants without detectable coronary artery calcium.
CONCLUSIONS: Among individuals 30 to 50 years of age with low short-term risk, a high lifetime predicted risk of CVD is associated with concentric LV hypertrophy and increased AWT. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20541716     DOI: 10.1016/j.jcmg.2010.03.005

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  18 in total

1.  Lifetime risks of cardiovascular disease.

Authors:  Jarett D Berry; Alan Dyer; Xuan Cai; Daniel B Garside; Hongyan Ning; Avis Thomas; Philip Greenland; Linda Van Horn; Russell P Tracy; Donald M Lloyd-Jones
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

2.  Factors Associated With Left Atrial Remodeling in the General Population.

Authors:  Walter Oliver; Gwendolyn Matthews; Colby R Ayers; Sonia Garg; Sachin Gupta; Ian J Neeland; Mark H Drazner; Jarett D Berry; Susan Matulevicius; James A de Lemos
Journal:  Circ Cardiovasc Imaging       Date:  2017-02       Impact factor: 7.792

3.  MRI-based determination of reference values of thoracic aortic wall thickness in a general population.

Authors:  Birger Mensel; Alexander Quadrat; Tobias Schneider; Jens-Peter Kühn; Marcus Dörr; Henry Völzke; Wolfgang Lieb; Katrin Hegenscheid; Roberto Lorbeer
Journal:  Eur Radiol       Date:  2014-05-11       Impact factor: 5.315

4.  Life-long physical activity restores metabolic and cardiovascular function in type 2 diabetes.

Authors:  Tim H A Schreuder; Martijn F H Maessen; Cees J Tack; Dick H J Thijssen; Maria T E Hopman
Journal:  Eur J Appl Physiol       Date:  2013-12-20       Impact factor: 3.078

Review 5.  Clinical applications of multiparametric CMR in left ventricular hypertrophy.

Authors:  Sabrina Nordin; Luke Dancy; James C Moon; Daniel M Sado
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-03       Impact factor: 2.357

6.  Impact of Abdominal Obesity on Proximal and Distal Aorta Wall Thickness in African Americans: The Jackson Heart Study.

Authors:  Fawaz Mzayek; Lisa E Wang; George Relyea; Xinhua Yu; James G Terry; Jeffrey Carr; Gregory W Hundley; Michael E Hall; Adolfo Correa
Journal:  Obesity (Silver Spring)       Date:  2019-07-22       Impact factor: 5.002

7.  High levels of thyroid-stimulating hormone are associated with aortic wall thickness in the general population.

Authors:  Till Ittermann; Roberto Lorbeer; Marcus Dörr; Tobias Schneider; Alexander Quadrat; Lydia Heßelbarth; Michael Wenzel; Ina Lehmphul; Josef Köhrle; Birger Mensel; Henry Völzke
Journal:  Eur Radiol       Date:  2016-03-14       Impact factor: 5.315

8.  Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study.

Authors:  Alice Y Chang; June Oshiro; Colby Ayers; Richard J Auchus
Journal:  Clin Endocrinol (Oxf)       Date:  2015-12-24       Impact factor: 3.478

9.  Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study.

Authors:  Jacob W Groenendyk; Parag Shukla; Amit K Dey; Youssef A Elnabawi; Milena Aksentijevich; Harry Choi; Leonard D Genovese; Charlotte L Harrington; Balaji Natarajan; Aditya Goyal; Aarthi S Reddy; Justin Rodante; Mohammad Tarek Kabbany; Ahmed Sadek; Mina Al Najafi; Martin P Playford; Aditya A Joshi; Mark A Ahlman; Joel M Gelfand; David A Bluemke; Nehal N Mehta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-05       Impact factor: 9.236

10.  Echocardiographic Left Ventricular Mass Estimation: Two-Dimensional Area-Length Method is Superior to M-Mode Linear Method in Swine Models of Cardiac Diseases.

Authors:  Satoshi Miyashita; Nadjib Hammoudi; Shin Watanabe; Olympia Bikou; Kelly Yamada; Jaume Aguero; Koichi Nomoto; Taro Kariya; Kenneth Fish; Roger J Hajjar; Kiyotake Ishikawa
Journal:  J Cardiovasc Transl Res       Date:  2019-12-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.